Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 26, No 6 (2023)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

DERMATO-ONCOLOGY

Dermatofibrosarcoma protuberans: Under the mask of scar

Vertieva E.Y., Kayumova L.N., Bobkova A.E.

Abstract

Dermatofibrosarcoma protuberans (Darier–Ferrand) is a rare mesenchymal tumor of fibrohistiocytic genesis with moderate malignancy and low incidence of metastasis, the pathogenesis and etiology of which remain unclear. The diagnosis is based on the clinical picture of a reddish-brown dense plaque or papule that gradually becomes a painful node with ulceration. Histological examination reveals the infiltrate with a moire pattern in the dermis in the form of fusiform cells with diffuse CD34+ staining during immunohistochemical analysis. Treatment of dermatofibrosarcoma protuberans (Darier–Ferrand) is a serious problem due to the high tendency for recurrence after removal. The methods described in the literature include extensive excision, Mohs surgery, chemotherapy, radiation therapy and targeted treatment with an anticancer protein-tyrosine kinase inhibitor.

The authors present their own clinical observation of a patient with dermatofibrosarcoma protuberans (Darier–Ferrand) in whom a diagnostic error by only visual method and an incorrect treatment led to the worsening of skin process. The interest of this clinical observation lies in the difficulty of diagnosis during the initial visit, in the complexity of differential and morphological diagnosis.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):545-552
pages 545-552 views

DERMATOLOGY

Etiology, clinical manifestations, and oral microbiota in oral lichen planus: A review of the scientific literature

Teplyuk N.P., Stepanov M.A., Damdinova B.S., Lazareva P.I.

Abstract

Treatment of lichen planus of the oral mucosa remains one of the most complex and urgent problems in dermatovenerology and dentistry.

In the article, the authors present an analysis of current scientific studies on various aspects of lichen planus of the oral mucosa, including its etiology and prevalence, clinical manifestations, as well as the potential risk of malignant transformation and the microbiota of the oral cavity in patients with this pathology. Potential factors influencing the development of the disease and the possible impact of changes in the microbiota on the clinical course of lichen planus of the oral mucosa are considered.

To date, the etiopathogenetic mechanisms of the development of lichen planus of the oral mucosa remain not fully understood. The determination of pathogenesis and the use of differentiated, combined methods will allow us to propose an optimal strategy for the prevention of the disease, increase the effectiveness of its prediction and treatment.

The call for further research emphasizes the need to study the red lichen planus of the oral mucosa not as an independent nosology, but as a system of complex neurohumoral and immunoallergic changes, disorders that can affect the patient's quality of life.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):553-562
pages 553-562 views

Experience of using the interleukin-17A inhibitor secukinumab in the treatment of psoriasis and psoriatic arthritis

Molochkova Y.V., Petrova M.S., Molochkov V.A., Monaenkova M.K., Abalukhova E.D.

Abstract

Psoriasis is a chronic immune-inflammatory skin disease, which in 25–30% of cases occurs in combination with damage of the musculoskeletal system ― psoriatic arthritis. Nowadays, the leading role in the pathogenesis of psoriasis and psoriatic arthritis is assigned to the activation of the IL-23/IL-17 axis-key cytokines involved in the activation pathway of the effector activity of Th17 lymphocytes. The activity of proinflammatory cytokines secreted by Th17 cells in psoriasis and psoriatic arthritis is also confirmed by the high efficiency of targeted therapy aimed specifically at this pathway. One of the modern genetically engineered biological drugs blocking IL-17 which is used worldwide in the treatment of psoriasis and psoriatic arthritis is secukinumab, a recombinant, fully human monoclonal antibody of high affinity directed against IL-17A.

The article presents data from own 52-week follow-up of secukinumab use in 40 patients with severe and moderate-severe psoriasis which was combined with psoriatic arthritis in 67.5% of cases and demonstrates high efficacy, survival and satisfactory tolerability of this therapy.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):563-574
pages 563-574 views

Psoriatic onychodystrophy: Clinical course, diagnosis and therapeutic aspects

Taganov A.V., Molochkov A.V., Kulikova N.G., Ali Mohammad A., Monaenkova M.K., Zaslavsky D.V., Kozlova D.V.

Abstract

Psoriatic onychodystrophy is observed in about 80% of patients with psoriasis. Psoriasis can affect two nail structures ― the matrix and the nail bed.

Involvement of the nail matrix in the pathological process can lead to the formation of leukonychia, thimble symptom, red spots in the area of the hole and destruction of the nail plate. On the other hand, the lesion of the nail bed is characterized by the formation of onycholysis, subcutaneous hyperkeratosis and subcutaneous hemorrhages.

Nail lesions in psoriasis are accompanied by functional disorders and aesthetic defects, and also indicate a severe course of psoriasis.

Treatment of psoriatic onychodystrophy includes topical medications, systemic therapy in cases accompanied by extensive skin lesions.

This article is an overview of the main clinical features, diagnostic issues and evaluation methods, as well as treatment options for nail psoriasis.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):575-596
pages 575-596 views

Psychosomatic aspects of vitiligo. A review of the literature

Mohammed Al-Janabi A., Dorozhenok I.Y., Lomonosov K.M.

Abstract

The active interest of researchers in the topic of vitiligo is due to both the potential for optimizing the treatment of chronic dermatosis of unknown etiology and the high psychosocial significance of the problem, which goes beyond the purely medical sphere.

The review deals with psychosomatic aspects of vitiligo: stressful manifestations; stigmatization and quality of life of patients with vitiligo; nosogenic (secondary) and comorbid vitiligo mental disorders; the article considers complex approaches to therapy, taking into account psychosomatic factors. The literature was searched in the following databases: PubMed, Scopus, MedLine, Embase, Cochrane, Russian State Library, the Sechenov Central Science Medical Library.

It seems extremely relevant and promising to develop a clinical typology of comorbid vitiligo psychosomatic disorders with the development of clinical recommendations for the identification, routing and therapy of an extensive contingent of patients with chronic dermatosis.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):597-604
pages 597-604 views

Experience of using benzoyl peroxide and clindamycin gel in the treatment of mild and moderate acne

Olisova O.Y., Shepeleva A.V., Kayumova L.N.

Abstract

BACKGROUND: Acne is an actual problem for both patients and doctors of different specialties, especially dermatovenerologists and cosmetologists. Up to 85% of young people are affected by the disease. Skin lesions on the face and lack of effect of previously administered therapy are often accompanied by severe psychosocial maladjustment even in mild forms of dermatosis. In addition, recently there has been a tendency towards increased resistance of Cutibacterium acnes to antibacterial agents, which requires the development of drugs, including those to prevent antibiotic resistance.

AIM: Clinical and morphofunctional assessment of the effectiveness and tolerability of the Zerkalin Intensive gel (benzoyl peroxide and clindamycin) in patients with mild to moderate acne.

MATERIALS AND METHODS: the study involved 30 patients with acne (28 women and 2 men) aged 18 to 34 years, 4 of them had mild severity, 26 had moderate severity. All patients applied benzoyl peroxide and clindamycin gel once a day in the evening, the observation period was 12 weeks. Dermatological examination was carried out visually with a simple count of inflammatory lesions (papules, pustules). In order to assess the morphofunctional parameters of facial skin, all patients underwent a non-invasive digital study using the Capricorn AI Intelligent Imager Bitmoji device, based on 3D visualization. To study the impact of the disease on various aspects of the patient's life and as an effectiveness criterion, the Dermatology life Quality Index (DLQI) was used.

RESULTS: in all patients using the benzoyl peroxide and clindamycin gel there was a regression of inflammatory and non-inflammatory elements and a decrease in post-acne phenomenon, while an improvement in the condition of the skin process was registered within the first 2–4 weeks. As a result of the treatment, complete cleansing of the skin was achieved in 8 patients, significant improvement in 17, and improvement in 5. At the end of the entire observation period, according to the questionnaire, the subjects observed a decrease in DLQI compared with the baseline (18.4±3.03 versus 3.03±0.15; p <0.05), which indicates an improvement of the quality of life and psychoemotional state of patients and the effectiveness of therapy.

CONCLUSION: Benzoyl peroxide and clindamycin gel for the treatment of mild to moderate acne is an effective remedy, especially with a predominance of pustular elements, which is confirmed based on the results of a visual examination and the positive dynamics of indicators of superficial and deep analysis of facial skin (sebumetry, corneometry, pigmentation, reactivity and level colonization by C. acnes). The gel was well tolerated by patients and did not cause any adverse events or allergic reactions.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):605-622
pages 605-622 views

The efficacy of using modern antiseptic drugs in ointment form in the treatment of pyoderma and secondarily infected dermatoses

Pritulo O.A., Borodavkin D.V., Kasaeva G.R., Ravlyuk D.A.

Abstract

BACKGROUND: Pyoderma is one of the most common diseases of the skin and its derivatives. Traditionally, topical antibacterial drugs are used as first-line drugs, but the growth of antibiotic resistance limits their use, and therefore the search for new promising forms of antiseptic drugs remains an urgent task. An antiseptic agent must have a wide antimicrobial spectrum, not irritate the skin and mucous membranes, and remain active for a long time; the antiseptic benzyldimethyl-myristoylamino-propylammonium ointment meets all these requirements.

AIM: to evaluate the efficacy and safety of 0.5% benzyldimethyl-myristoylamino-propylammonium ointment in the treatment of pyoderma and secondarily infected dermatoses.

MATERIALS AND METHODS: We followed 36 patients with identified polyresistance to topical antibacterial drugs aged 18 to 63 year. 1st group consisted of 22 patients with clinical forms of superficial pyoderma: superficial folliculitis ― 8 (36.4%) cases, sycosis vulgaris ― 4 (18.2%), impetigo vulgaris ― 4 (18.2%), dry streptoderma ― 3 (13.6%), paronychia ― 3 (13.6%). The 2nd cohort included 14 human test subjects with secondarily infected dermatosis: nummular eczema ― 6 cases (42.8%), atopic dermatitis ― 5 (35.8%), secondarily infected contact allergic dermatitis ― 3 (21.4%).

RESULTS: As a result of monotherapy with 0.5% benzyldimethyl-myristoylamino-propylammonium ointment in the pyoderma group, clinical recovery (with DIDS=0) was observed in 91.7% of the subjects. The most common dermoscopic pattern was a necrotic rod, the final one was a light red background. Comprehensive treatment of secondarily infected dermatosis in patients of group II, a clinical cure was stated in 71.4% of cases, which is associated with the predominance of chronic, recurrent dermatoses in this cohort of the study, it was noted that dermatosis has a moderate effect on their lives. Initially, during dermatoscopy, there were signs of an acute stage of examination (yellow scales/crusts, punctate vessels, hemorrhages), after therapy ― a stationary stage (white scales).

CONCLUSION: Miramistin ointment 0.5% has demonstrated high tolerability and efficacy against various forms of superficial pyoderma and secondarily infected dermatosis and can be recommended for effective use in clinical practice.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):623-634
pages 623-634 views

Experience of successful use of intense pulsed light in the treatment of Shamberg patients

Arkatova E.A., Sidorenko O.A., Sidorenko E.E., Materikin I.A.

Abstract

Schamberg's disease (chronic purpura pigmentosa) is the most common type of pigmentary purpuric dermatosis, most commonly seen in men and primarily affecting the areas of the tibia, thighs, buttocks, trunk, or upper extremities, with a classic presentation characterized by petechiae, purpura, and enhancement skin pigmentation. This is a benign disease that is often asymptomatic and requires treatment if there are associated symptoms or if the patient wishes to improve a cosmetic defect.

Schamberg's disease is usually not difficult to diagnose, but its treatment can be challenging. The current standard of treatment for chronic purpura pigmentosa includes systemic and external drug therapy, correction of identified concomitant diseases that can maintain and worsen the course of cutaneous vasculitis. There are many other, including non-pharmacological, methods described in the literature, few of which have been shown to be effective. Considering the small number of studies on this topic, numerous exacerbations and the possibility of spontaneous resolution of the disease, patients’ concerns about residual pigmentation, the search for an optimal therapeutic approach remains an urgent task.

This article describes the experience of using broadband pulsed light in the treatment of Schamberg disease in a 34-year-old man. The equipment settings, diagram and exposure protocol for broadband pulsed light are presented. As a result of a follow-up examination carried out 1 month after treatment, a positive dynamic of the therapeutic process was determined: there were no new rashes, individual foci of the rash regressed completely, the remaining elements of the rash paled significantly. At a follow-up examination, four months after the therapy, a stable treatment result was recorded.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):635-644
pages 635-644 views

Human papillomavirus and its association with oral lichen planus

Starshinina V.A., Perlamutrov Y.N., Olhovskaya K.B.

Abstract

BACKGROUND: Oral lichen planus is a chronic disease with periods of exacerbations and remissions, requiring long-term symptomatic treatment and observation. Dermatosis can occur or worsen in the presence of different triggers, for example, due to the persistence of the human papillomavirus.

AIM: to explore the effect human papillomavirus on the characteristics oral lichen planus.

MATERIALS AND METHODS: 90 patients with oral lichen planus aged from 26 to 73 years (average age 55.61±1.00 years) were examined. Real-time polymerase chain reaction was used to detect human papillomavirus. The need for treatment of caries, Green–Vermillion and complex periodontal indices were used to analysis state of oral hygiene.

RESULTS: Human papillomavirus DNA was detected in 53 (58.88%) cases. Patients of this group were 4 years younger than other study participants; the duration of dermatosis is 2 years longer with a predominance of atrophic/erythematous and erosive/ulcerative forms. It was noted that indexes of caries and the complex periodontal were significantly (p=0,007 and p=0,030 respectively) higher compared to patients without papillomavirus infection.

CONCLUSION: It is found features of oral lichen planus in identifying human papillomavirus: early onset; severe of the disease with predominantly destructive forms; high prevalence of caries and periodontitis.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):645-652
pages 645-652 views

CHRONICLES

Chronicles of A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists (MSDC was founded on October 4, 1891). Bulletin of the MSDC meeting N 1154

Yakovlev A.B., Maximov I.S.

Abstract

On October 17, 2023, the 1154th meeting of the Moscow Society of Dermatovenerologists and Cosmetologists named after A.I. Pospelov took place.

The meeting was held in a face-to-face format. There were 118 participants in total. 65 applications were submitted for membership in MSDC! Due to the large number of applicants for membership in the MSDC, a list vote was held: approved unanimously.

Two reports were presented in the clinical part of the meeting: Pityriasis rubra pilaris after suffering COVID-19 (Sechenov University); A clinical case of a rare hereditary disease ― erythrokeratoderma (State Scientific Center of Dermatovenereology and Cosmetology).

Reports were made in the scientific part of the meeting: Topical therapy for xerosis of various genesis (Sechenov University); Modern paradigms for improving the effectiveness of treatment of allergodermatoses taking into account violations of the skin microbiome (Federal Scientific and Clinical Center of Intensive Care and Rehabilitation); The use of transcranial electrical stimulation in patients with atopic dermatitis (Sechenov University).

Russian Journal of Skin and Venereal Diseases. 2023;26(6):653-660
pages 653-660 views

PHOTO GALLERY

Photogallery. Genodermatoses. Part II

Teplyuk N.P., Grabovskaya O.V., Kochergin N.G., Kayumova L.N.

Abstract

Genodermatoses are a group of hereditary diseases primarily affecting the skin. To date, there are more than two hundred genetically determined dermatoses representing about 35% of all genetic diseases and 10% of all skin diseases. Genodermatoses can be caused by mutations in a single gene or the interaction of several genes and environmental factors. Hereditary diseases are characterized by a wide variety of phenotypic manifestations and the diagnostic complexity which represents a serious problem in modern dermatology.

We present a gallery of hereditary dermatoses.

Unna-Tost disease is a genodermatosis inherited in an autosomal dominant manner and characterized by diffuse excessive keratinization of the skin on the palms and soles, manifesting in the first to second year of life.

Buschke-Fischer-Brauer punctate palmoplantar keratoderma is a late-developing focal dermatosis in which painful hyperkeratotic papules can occur when traumatized.

Ehlers-Danlos syndrome is a condition demonstrating skin hyperextensibility and a number of typical symptoms of the skeletal and cardiovascular systems.

Progeria manifests as premature skin aging, affecting the endocrine, skeletal, cardiovascular, and other systems of the body, as well as increasing the risk of developing malignant neoplasms of internal organs and skin.

Congenital ichthyosiform erythroderma of Brocq is a severe chronic skin disease with autosomal recessive inheritance, which follows the pattern of lamellar ichthyosis but to a milder degree.

X-linked ichthyosis, a hereditary "darkening" condition, occurs only in males and is characterized by impaired keratinization and the presence of gray-black scales on the skin.

Lamellar ichthyosis is an autosomal recessive dermatosis characterized by generalized skin involvement.

Netherton syndrome is a rare condition characterized by a combination of ichthyosis with structural anomalies of the hair shaft and atopy.

Russian Journal of Skin and Venereal Diseases. 2023;26(6):661-665
pages 661-665 views


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies